CorRen Medical is building an autonomous, hands-free ultrasound technology, guided by our proprietary AI technology and clinical analysis algorithms to enable early detection of Peripheral Artery Disease (PAD), inform personalized therapy, and improve patients’ outcomes
Peripheral Artery Disease
PAD is the 2nd leading cause of morbidity and mortality in the western world, and its prevalence is expected to rise to 19 Million Americans by 2050.
8.5-12 Million patients impacted
PAD Economic Burden is $250B annually
60% of PAD patients have Coronary Artery Disease (CAD)
11% of PAD patients have Chronic Limb Threatening
CorRen Medical’s suite of disruptive ultrasound innovations improve diagnosis and treatment.
Self-guiding, multi-element technology for enhanced PAD diagnosis and treatment
Non-invasive hemodynamic monitoring system for accurate clinical detection and personalized therapy guidance